The Discounted Cash Flow (DCF) valuation of Regenxbio Inc (RGNX) is (8.23) USD. With the latest stock price at 9.69 USD, the upside of Regenxbio Inc based on DCF is -185.0%.
Based on the latest price of 9.69 USD and our DCF valuation, Regenxbio Inc (RGNX) is a sell. selling RGNX stocks now will result in a potential gain of 185.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.1% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (29.48) - (5.76) | (8.23) |
| Upside | -404.3% - -159.4% | -185.0% |